Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03968445 · ClinicalTrials.gov registry record · Phase 1

Neuroinflammation After Myocardial Infarction - Imaging Substudy

A Phase 1 study of Myocardial Infarction, sponsored by University of Alabama at Birmingham.

Active
Registry status
Phase 1
Development phase
6
Enrollment target
1
Study location

NCT03968445 is a Phase 1 study of Myocardial Infarction that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 6 participants, below the 4,682-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03968445, a Phase 1 study of Myocardial Infarction, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to see if positron emission tomography and magnetic resonance imaging (PET/MRI) with an investigational drug called \[18F\]DPA-714 will show inflammation in the brain after a heart attack. This study may help physicians and researchers better understand the role of brain inflammation in heart disease and develop new treatments to protect the brain.

Conditions Studied

Myocardial Infarction

Interventions

  • DRUG [18F]DPA-714-PET/MRI

Study Locations (1)

Alabama

  • University of Alabama at Birmingham Medical Center - Birmingham

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-10-17
Est. Completion 2028-10
Phase Phase 1

Sponsor

University of Alabama at Birmingham

1,160 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03968445

The ClinicalTrials.gov registry entry for NCT03968445 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,682-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (100% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which [18F]DPA-714-PET/MRI is the first listed.

NCT03968445 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03968445 about?

NCT03968445 is a clinical study titled "Neuroinflammation After Myocardial Infarction - Imaging Substudy". The purpose of the study is to see if positron emission tomography and magnetic resonance imaging (PET/MRI) with an investigational drug called \[18F\]DPA-714 will show inflammation in the brain after a heart attack. This study may help physicians and researchers better understand the role of brain ...

What is the current status of trial NCT03968445?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2019-10-17. Estimated completion is 2028-10.

What conditions does trial NCT03968445 study?

This clinical trial studies the following conditions: Myocardial Infarction.

What interventions are being tested in trial NCT03968445?

The interventions under investigation include: [18F]DPA-714-PET/MRI (DRUG).

Who is sponsoring clinical trial NCT03968445?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03968445 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myocardial Infarction

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.